Thalidomide, an antiangiogenic agent with clinical activity in cancer

被引：21

作者：

Ng, SSW ^{[1
]}

Brown, M ^{[1
]}

Figg, WD ^{[1
]}

机构：

[1] Natl Canc Inst, Mol Pharmacol Sect, Canc Therapeut Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2002年 / 56卷 / 04期

关键词：

thalidomide; HIV-infection; bFGF; VEGF;

D O I：

10.1016/S0753-3322(02)00177-4

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Despite the teratogenic past of thalidomide, there is recent evidence indicating the drug's efficacy in the management of various diseases from immune disorders to cancers. The history, pharmacodynamic and pharmacokinetic properties of thalidomide in the clinic are discussed in this review article. (C) 2002 Editions scientifiques et medicales Elsevier SAS.

引用

页码：194 / 199

页数：6

共 46 条

[1]

ANDO Y, UNPUB CLIN CANC RES

[2]

Barlogie B, 2000, BLOOD, V96, p514A

[3] Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent [J].

Bauer, KS ;

Dixon, SC ;

Figg, WD .

BIOCHEMICAL PHARMACOLOGY, 1998, 55 (11) :1827-1834

[4]

BOASBERG P, 2000, P AM SOC CLIN ONCOL, V19, P609

[5] Thalidomide: Current and potential clinical applications [J].

Calabrese, L ;

Fleischer, AB .

AMERICAN JOURNAL OF MEDICINE, 2000, 108 (06) :487-495

[6] Thalidomide for night sweats in patients with advanced cancer [J].

Calder, K ;

Bruera, E .

PALLIATIVE MEDICINE, 2000, 14 (01) :77-78

[7] Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity [J].

Ching, LM ;

Browne, WL ;

Tchernegovski, R ;

Gregory, T ;

Baguley, BC ;

Palmer, BD .

BRITISH JOURNAL OF CANCER, 1998, 78 (03) :336-343

[8] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

[9] Thalidomide for distressing night sweats in advanced malignant disease [J].

Deaner, P .

PALLIATIVE MEDICINE, 1998, 12 (03) :208-209

[10] Thalidomide and dexamethasone combination for refractory multiple myeloma [J].

Dimopoulos, MA ;

Zervas, K ;

Kouvatseas, G ;

Galani, E ;

Grigoraki, V ;

Kiamouris, C ;

Vervessou, E ;

Samantas, E ;

Papadimitriou, C ;

Economou, O ;

Gika, D ;

Panayiotidis, P ;

Christakis, I ;

Anagnostopoulos, N .

ANNALS OF ONCOLOGY, 2001, 12 (07) :991-995

← 1 2 3 4 5 →